ANIK: Anika Therapeutics Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand anikatherapeutics.com (ANIK)

Anika Therapeutics revenues rely on demand in sports medicine and an aging population. The P/E to growth rate dynamics visualize the asset's fundamental stability, where the value of 0.11 corresponds to the current metric. Biopolymer patents and stringent FDA oversight create high barriers to entry. The company's strategy is based on transitioning to comprehensive joint regeneration systems to increase margins.

Anika Therapeutics (ANIK) - PEG Multiple from 07/04/2022 to 11/16/2026

Anika Therapeutics Inc. (ANIK) - metric breakdowns and financial figures

Fundamental company analysis:ANIK (Anika)
Manufactured products of Anika Therapeutics, Inc.

Steady demand for orthopedic solutions amid an aging population creates a foundation for growth for Anika Therapeutics (ANIK), although strict medical reimbursement limits constrain pricing power. By analyzing the PEG ratio, an investor compares the asset's market value with earnings growth rates: a ratio below one signals that the company is undervalued relative to its scaling, indicating the potential of an undervalued asset.

Competing companies

Growth-Adjusted Market Cap to Net Income Boston Scientific|PEG Multiple EW (Edwards)|RMD (ResMed Inc.) - Market Cap to Earnings and Growth Ratio|PODD: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Zimmer Biomet Corp|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Align Technology Inc (ALGN)|GMED (Globus Medical) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (TransMedics Group Inc)|Price/Earnings to Growth Multiple ATEC (Alphatec)|AORT (CryoLife) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis Inc. ENOV|IART - Price/Earnings to Growth Multiple|Establishment Labs Corp - PEG Multiple|Price to Earnings Adjusted for Growth Rate Beta Bionics Inc|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Corp) - PEG Multiple|Axogen Corp (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Medical Inc. OFIX|Price/Earnings to Growth Ratio Bioventus BVS|PEG Multiple OrthoPediatrics Corp. KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Inc) - Price/Earnings to Growth Multiple|RxSight, Inc. - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Stereotaxis Inc STXS|Price/Earnings to Growth Ratio Neuronetics Inc. (STIM)|Sight Sciences, Inc. (SGHT) - Price to Net Income Growth Ratio|orchestrabiomed.com - Price/Earnings to Growth Multiple|PEG Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical VANI|Xtant Medical (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne Medical Technologies Corp.)|Price/Earnings to Growth Ratio modular-medical.com|Price to Earnings Adjusted for Growth Rate myomo.com MYO|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|rewalk.com - Company Value to Earnings Growth Ratio|AMIX: PEG Multiple|Growth-Adjusted P/E Ratio IVF|Price/Earnings to Growth Ratio bonebiologics.com|Growth-Adjusted P/E Ratio AXNX (Axonics, Inc)|Price/Earnings to Growth Ratio BIOLASE Inc. (BIOL)|Dynatronics - Growth-Adjusted P/E Ratio|PEG Multiple FNA (Paragon 28 Corp)|invobioscience.com (INVO) - Price to Earnings Adjusted for Growth Rate